PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Pilocarpine hydrochloride - Dry mouth
PAD Profile : Pilocarpine hydrochloride - Dry mouth
Keywords :
Xerostomia, Sjogren's syndrome
Brand Names Include :
Salagen
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Tablets
Important Information :
Treatment of dry eye and dry mouth in Sjögren's syndrome.
For initiation and stabilisation for 3 months by the specialist team before any request to transfer prescribing to primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 February 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.
Associated BNF Codes
12. Ear, Nose and Oropharynx
12.03.05. Treatment of dry mouth